Organ-Sparing Treatment of Advanced Bladder Cancer

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Strahlentherapie und Onkologie (Print)

• Publication date

  2007-04-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/s00066-007-1651-z
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Combined Effect of Tumor Necrosis Factor-alpha and Ionizing Radiation on the Induction of Apoptosis in 5637 Bladder Carcinoma Cells

  2006cited by this paper
• A Clinical Study of Hypoxia Using Endogenous Hypoxic Markers and Polarographic Oxygen Electrodes

  2006cited by this paper
• Irradiation specifically sensitises solid tumour cell lines to TRAIL mediated apoptosis

  2005cited by this paper
• Combined-Modality Treatment and Organ Preservation in Bladder Cancer

  2005cited by this paper
• Organ-Sparing Treatment in Muscle-Invasive Bladder Cancer

  2005influential reference
• Current Status of Radiation Therapy and Combined-Modality Treatment for Bladder Cancer

  2004cited by this paper
• In vitro investigations of new therapeutic agents on bladder tumor cell lines

  2004cited by this paper
• Concurrent cisplatin, 5-fluorouracil, leucovorin, and radiotherapy for invasive bladder cancer.

  2003influential reference
• Progress in the chemotherapy of metastatic cancer of the urinary tract

  2003cited by this paper
• Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results.

  2002cited by this paper
• Chemotherapy with an every‐2‐week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin‐based therapy

  2001cited by this paper
• Combination paclitaxel, carboplatin, and gemcitabine is an active treatment for advanced urothelial cancer.

  2001cited by this paper
• Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases: a Southwest Oncology Group Study.

  2001influential reference
• Prognostic factors in invasive bladder carcinoma treated by combined modality protocol (organ-sparing approach).

  2000cited by this paper
• Radiation therapy and concomitant paclitaxel/carboplatin chemotherapy for muscle invasive transitional cell carcinoma of the bladder: A well‐tolerated combination

  2000cited by this paper
• Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy.

  2000cited by this paper
• Gemcitabine/paclitaxel-based three-drug regimens in advanced urothelial cancer.

  2000cited by this paper
• An update of combined modality therapy for patients with muscle invading bladder cancer using selective bladder preservation or cystectomy.

  1999cited by this paper
• Simultaneous paclitaxel and radiotherapy: initial clinical experience in lung cancer and other malignancies.

  1997cited by this paper
• Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group.

  1996cited by this paper
• RTOG Late Effects Working Group. Overview. Late Effects of Normal Tissues (LENT) scoring system.

  1995cited by this paper
• Analysis of failure following definitive radiotherapy for invasive transitional cell carcinoma of the bladder.

  1995cited by this paper
• In vitro studies of Taxol as a radiation sensitizer in human tumor cells.

  1994cited by this paper
• Organ-sparing treatment of advanced bladder cancer: a 10-year experience.

  1994cited by this paper
• Blood tests and prognosis in bladder carcinomas treated with definitive radiotherapy.

  1993cited by this paper
• Reappraisal of the role of radical radiotherapy and salvage cystectomy in the treatment of invasive (T2/T3) bladder cancer.

  1988cited by this paper
• Primary radical radiotherapy for T3 transitional cell cancer of the bladder: an analysis of survival and control.

  1986cited by this paper

• Fast progression in non–small cell lung cancer: results from the randomized phase III OAK study evaluating second-line atezolizumab versus docetaxel

  2021cites this paper
• Executive Summary of the American Radium Society Appropriate Use Criteria for Radiation Treatment of Node-Negative Muscle Invasive Bladder Cancer.

  2020cites this paper
• Incidence and outcome of salvage cystectomy after bladder sparing therapy for muscle invasive bladder cancer: a systematic review and meta-analysis

  2020cites this paper
• Biomarkers for Predicting Clinical Outcomes of Chemoradiation-Based Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer

  2018cites this paper
• A comparison of morbidity following conformal versus intensity-modulated radiotherapy for urinary bladder cancer

  2014cites this paper
• [Concomitant chemoradiotherapy for muscle-invasive bladder cancer: current knowledge, controversies and future directions].

  2014cites this paper
• Trimodality Therapy for Bladder Conservation in Treatment of Invasive Bladder Cancer

  2013cites this paper
• Trimodality treatment in the conservative management of infiltrating bladder cancer: a critical review of the literature.

  2013cites this paper
• Stellenwert der Radiochemotherapie beim Harnblasenkarzinom

  2012cites this paper
• Treatment Results of Radiation Therapy for Muscle-Invasive Bladder Cancer

  2010cites this paper
• Radiochemotherapy for bladder cancer.

  2009cites this paper
• Clinical experience with radiotherapy alone and radiochemotherapy with platin based regimens in organ-sparing treatment of invasive bladder cancer.

  2009cites this paper
• Treatment Options for High-Risk T1 Bladder Cancer

  2008cites this paper
• The Role of Radiation Therapy after Incomplete Resection of Penile Cancer

  2008cites this paper
• Management of superficial recurrences in an irradiated bladder after combined-modality organ-preserving therapy.

  2008cites this paper
• Clinical Results of a Concomitant Boost Radiotherapy Technique for Muscle-Invasive Bladder Cancer

  2008cites this paper
• Status Quo and Future Perspectives of Radiochemotherapy

  2008cites this paper
• X-ray volume imaging in bladder radiotherapy verification.

  2006cites this paper
• Proton beam therapy for invasive bladder cancer: a prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy.

  2006cites this paper
• Organ-Sparing Treatment in Muscle-Invasive Bladder Cancer

  2005cites this paper
• Initial Experience of Bladder Preservation Therapy Using Chemoradiotherapy with Regional Hyperthermia for Muscle-invasive Bladder Cancer

  2005cites this paper